The following represents disclosure information provided by authors of this abstract. The Gastrointestinal Cancers Symposium Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
Transarterial infusion chemotherapy with cisplatin plus S-1 for treating hepatocellular carcinoma: Results of a phase I trial.
Tetsuji Terazawa
No relevant relationships to disclose
Shunsuke Kondo
No relevant relationships to disclose
Chigusa Morizane
No relevant relationships to disclose
Tomohiro Yamaguchi
No relevant relationships to disclose
Satoshi Shimizu
No relevant relationships to disclose
Shuichi Mitsunaga
No relevant relationships to disclose
Masafumi Ikeda
No relevant relationships to disclose
Hideki Ueno
No relevant relationships to disclose
Takuji Okusaka
No relevant relationships to disclose